1-4 of 4
Marc-Antoine May
Close
Sort by
Journal Articles

Frequency of Anti-PF4/Heparin Antibodies in Patients Treated with Extra-Corporeal Membrane Oxygenation and Detection By Sensitized Serotonin Release Assay of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Caroline Vayne, PharmD, Marc-Antoine May, MD, Thierry Bourguignon, MD PhD, Eric Lemoine, MD, Eve-Anne Guéry, PharmD, Jérôme Rollin, PhD, Yves Gruel, MD PhD, Claire Pouplard, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1143.
https://doi.org/10.1182/blood-2018-99-114571
Published: 2018
Journal Articles

Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia

Jérôme Rollin, Claire Pouplard, Marie-Pierre Gratacap, Dorothée Leroux, Marc-Antoine May, Michel Aupart, Valérie Gouilleux-Gruart, Bernard Payrastre, Yves Gruel
Journal: Blood
Blood (2012) 120 (6): 1309–1316.
https://doi.org/10.1182/blood-2012-04-424044
Published: 2012
Includes: Supplemental data
Journal Articles

Influence of Protein Tyrosine Phosphatase Polymorphisms on the Development of Antibodies to Platelet Factor 4 and the Risk of Heparin-Induced Thrombocytopenia.

Jerôme Rollin, PhD, Claire Pouplard, PharmD, PhD, Dorothee Leroux, PharmD, Marc-Antoine May, MD, Yves Gruel, MD
Journal: Blood
Blood (2010) 116 (21): 3683.
https://doi.org/10.1182/blood.V116.21.3683.3683
Published: 2010
Journal Articles

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

Dorothee Leroux, Claire Pouplard, PharmD, PhD, Benoit Guillet, MD, PhD, Beatrice Cosne, Marc Antoine May, MD, Yves Gruel, MD
Journal: Blood
Blood (2008) 112 (11): 3414.
https://doi.org/10.1182/blood.V112.11.3414.3414
Published: 2008